Rutgers New Jersey — Newark, New Jersey

Rutgers New Jersey is a clinical research site located in Newark, New Jersey, United States 07103.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Rutgers New Jersey has participated in 1 clinical trials.

Therapeutic areas: Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN).

Sponsors: Inovio Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers New Jersey?

Rutgers New Jersey has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers New Jersey conducted?

Rutgers New Jersey has 1 clinical trials on record. Their work covers Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN).

Is Rutgers New Jersey accredited by Crixeo Health?

Rutgers New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.